Docebo Inc.: Form 40-F for the period ended Dec 31, 2023
Filed with the SEC on Feb 23, 2024 and accepted by EDGAR at Feb 23, 2024, 07:36 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $180.8m | ifrs-full:RevenueFromContractsWithCustomers |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $34.5m | ifrs-full:CostOfSales |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $146.3m | ifrs-full:GrossProfit |
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$3.7m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $2.0m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2023-01-01 to 2023-12-31 | $2.8m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $0.08 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $0.09 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $16.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $635.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2023-12-31 | $72.0m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2023-12-31 | $127.2m | ifrs-full:CurrentAssets |
| Total assets | At period end2023-12-31 | $158.4m | ifrs-full:Assets |
| Current liabilities | At period end2023-12-31 | $100.7m | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2023-12-31 | $107.7m | ifrs-full:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $50.7m | ifrs-full:Equity |
| Shares outstanding | At period end2023-12-31 | 30,305,156 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001628280-24-006515. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.